Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blood Coagulation Disorder: early-phase trial registry
1 of 5 indexed Blood Coagulation Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Blood Coagulation Disorder: 5 US clinical trials tracked, 1 recruiting.
Blood Coagulation Disorder is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Swanson Center, running 1 of these trials.
Enrollment posture brief
Registry condition blood-coagulation-disorder
OPEN 1 | RECR 20% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Blood Coagulation Disorder lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blood Coagulation Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blood Coagulation Disorder is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Blood Coagulation Disorder research.
Swanson Center accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Blood Coagulation Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Blood Coagulation Disorder research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Investigation of the Genetics of Hematologic Diseases
St. Jude Children's Research Hospital
NCT02720679
Study of Abnormal Blood Clotting in Children With Stroke
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00001927
Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients
Swanson Center
NCT03821597
AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)
Spur Therapeutics
NCT04272554
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Spark Therapeutics
NCT03734588
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Blood Coagulation Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blood Coagulation Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blood Coagulation Disorder page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Blood Coagulation Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Swanson Center sponsors the most Blood Coagulation Disorder trials on record, review their full trial history before evaluating a specific study. See Swanson Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Coagulation Disorder condition card totals 5 registered trials; most-linked intervention No sequential compression.; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.